Description
Primary CVD prevention programme (ages 40–65). Launched in 2018, the programme uses proactive screening (symptoms, family history, smoking status, blood pressure, BMI, cardiac auscultation, and blood lipids and glucose), followed by cardiovascular risk calculation using SCORE and subsequent lifestyle advice, diagnostic testing, and drug treatment where indicated. The State Methodological Guidance Authority in Cardiology initiated an update to the programme in late 2025 following publication of the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias.Program launch date
Since 2018Responsible entity
Ministry of Health (National Health Service)Available results and quality metrics
Not available.Limitations / comments
When SCORE-2 was introduced, most individuals aged 40–65 in Latvia were classified as high or very high risk, which created uncertainty regarding the usefulness of risk calculation and contributed to a low response rate. The updated 2025 definitions of high and very high risk according to SCORE-2 will enable more accurate stratification of individuals and are therefore expected to be adopted more widely by general practitioners. In addition, risk enhancers are planned to be incorporated into future decision algorithms, and bureaucratic obstacles will be minimized.